Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CLASS ACTION UPDATE for AVEO, STMP, AMR and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, March 21, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)
Class Period:
August 4, 2016 - January 31, 2019
Lead Plaintiff Deadline: April 26, 2019
Join the action: https://www.zlk.com/pslra-1/aveo-pharmaceuticals-inc-loss-form?wire=3

Allegations: AVEO Pharmaceuticals, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) the TIVO‑3 trial was inadequately designed to address the OS concerns regarding AVEO’s lead candidate drug, tivozanib, from the TIVO-1 trial presented in June 2013; (ii) tivozanib had insufficient survival data to meet FDA approval following its initial 2013 rejection; (iii) this lack of sufficient survival data would put tivozanib at greater risk of delayed FDA approval; and (iv) as a result, AVEO’s public statements were materially false and misleading at all relevant times.

To learn more about the AVEO Pharmaceuticals, Inc. class action contact jlevi@levikorsinsky.com.

Stamps.com Inc. (NASDAQ: STMP)
Class Period:
May 3, 2017 - February 21, 2019
Lead Plaintiff Deadline: April 29, 2019
Join the action: https://www.zlk.com/pslra-1/stamps-com-inc-loss-form?wire=3

Allegations: Stamps.com Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company’s financial results depended on the manipulation of a USPS program that cost USPS an estimated $235 million per year; and (ii) as a result, the Company’s business was unsustainable and its financial results were highly misleading.

To learn more about the Stamps.com Inc. class action contact jlevi@levikorsinsky.com.

Alta Mesa Resources, Inc. (AMR) f/k/a Silver Run Acquisition Corporation II (NASDAQCM: AMR)
Class Period:
Purchasers of Silver Run II securities March 24, 2017-February 25, 2019 and investors who held Silver Run II Class A common stock as of January 22, 2018 and were entitled to vote concerning Silver Run II's acquisition of Alta Mesa and Kingfisher Midstream LLC
Lead Plaintiff Deadline: April 1, 2019
Join the action: https://www.zlk.com/pslra-1/alta-mesa-resources-inc-amr-f-k-a-silver-run-acquisition-corporation-ii-loss-form?wire=3

Allegations: During the class period, Alta Mesa Resources, Inc. (AMR) f/k/a Silver Run Acquisition Corporation II made materially false and/or misleading statements and/or failed to disclose that: (1) Alta Mesa and Kingfisher did not possess “superior quality” and “[w]orld [c]lass” assets as compared to other operators in the oil and gas industry; (2) Alta Mesa faced significant operational setbacks; (3) several major oil producers had steered assets away from production in the region in which Alta Mesa operates; and (4) Kingfisher and Alta Mesa were not on track to achieve the earnings and production estimates provided in the Proxy and Defendants had no reasonable basis to believe and did not believe that Kingfisher and Alta Mesa would achieve these estimates.

To learn more about the Alta Mesa Resources, Inc. (AMR) f/k/a Silver Run Acquisition Corporation II class action contact jlevi@levikorsinsky.com.

Mobile TeleSystems PJSC (NYSE: MBT)
Class Period:
March 19, 2014 - March 7, 2019
Lead Plaintiff Deadline: May 20, 2019
Join the action: https://www.zlk.com/pslra-1/mobile-telesystems-pjsc-loss-form?wire=3

Allegations: Mobile TeleSystems PJSC made materially false and/or misleading statements and/or failed to disclose that: (1) MTS and its subsidiary were involved in a scheme to pay $420 million in bribes in Uzbekistan; (2) consequently, MTS knew or should have known it would be forced to pay substantial fines to the U.S. government after disclosing in 2014 that the U.S. Department of Justice and Securities and Exchange Commission were investigating its Uzbekistan operations; (3) MTS’ level of cooperation with the U.S. government and remediation was lacking; (4) due to the aforementioned misconduct, MTS would be forced to pay approximately $850 million in criminal penalties to the U.S. government; and (5) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

To learn more about the Mobile TeleSystems PJSC class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today